UPDATE: Stifel Nicolaus Upgrades Omega Healthcare Investors to Buy

Stifel Nicolaus is out with its report today on Omega Healthcare Investors OHI, upgrading OHI from Hold to Buy. In its report, Stifel Nicolaus writes, "With well covered 11% dividend yield and valuation below NAV, we believe OHI shares offer a compelling value that more than prices in known and risk of future Medicare and Medicaid rate cuts for skilled nursing operators. We are upgrading to Buy with $18 target price." At the time of posting, shares of OHI were trading at $14.65, up 0.34% from Monday's close.